The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency
Siberian State Medical University
Orden of the Red Banner of Labor City Clinical Hospital No. 1
Rostov State Medical University
Regional Clinical Hospital
Pavlov First Saint Petersburg State Medical University
Vladimirsky Moscow Regional Research Clinical Institute
State Novosibirsk Regional Clinical Hospital;
Novosibirsk State Medical University
Pyatigorsk City Clinical Hospital No. 2
Semashko Nizhny Novgorod Regional Clinical Hospital
Seredavin Samara Regional Clinical Hospital
N. Bechtereva Institute of the Human Brain
Medical and Sanitary unit «Neftyanik»
Altai State Medical University
Academician I.P. Pavlov First Saint Petersburg State Medical University
Rostov Regional Clinical Hospital
Wagner Perm State Medical University
City Clinical Hospital No. 7;
Kazan State Medical Academy — Branch of the Russian Medical Academy of Continuing Professional Education
Municipal Filatov Clinical Hospital No. 15
Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2
Journal: Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;123(4): 37‑47
To cite this article:
Boyko AN, Alifirova VM, Lukashevich IG, Goncharova ZA, Greshnova IV, Zaslavsky LG, Kotov SV, Malkova NA, Mishin GN, Parshina EV, Poverennova IYe, Prakhova LN, Sivertseva SA, Smagina IV, Totolyan NA, Trinitatsky YuV, Trushnikova TN, Khabirov FA, Shchur SG, Artemyeva AV, Bolsun DD, Zinkina-Orikhan AV, Linkova YuN. Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova.
2023;123(4):37‑47. (In Russ.)
An email was sent to firstname.lastname@example.org with a confirmation link. Follow the link from the letter to complete the registration on the site.
Log in to the site using your account in one of the services